References of "DELWAIDE, Jean"
     in
Bookmark and Share    
Peer Reviewed
See detailLes modes de transmission du virus de l'hépatite C
Delwaide, Jean ULg; Gerard, Christiane ULg; Sondag, Danièle ULg et al

in Médecine & Chirurgie Digestives (1997), 26

Detailed reference viewed: 11 (6 ULg)
Full Text
Peer Reviewed
See detailLa vaccination contre les hépatites A et B
Delwaide, Jean ULg; Belaiche, Jacques ULg

in Revue Médicale de Liège (1997), 52(10), 639-643

Detailed reference viewed: 16 (0 ULg)
Full Text
See detailAnswers to frequently asked questions concerning hepatitis C
Gerard, Christiane ULg; Delwaide, Jean ULg

in Decker, R.; Troonen, H. (Eds.) Hepatitis C 1997: Essays and Expert Opinions on its Natural History, Epidemiology, Diagnosis and Therapy (1997)

Supporting a referral center in a university hospital, our staff is regularly exposed to amultitude of questions concerning hepatitis C from a great variety of individuals including laboratorians, general ... [more ▼]

Supporting a referral center in a university hospital, our staff is regularly exposed to amultitude of questions concerning hepatitis C from a great variety of individuals including laboratorians, general practitioners and their patients, nurses, gastroenterologists, and affiliated health care professionals. The following reflects our collective experience in answering the most frequently posed questions. [less ▲]

Detailed reference viewed: 9 (3 ULg)
Full Text
See detailAcromégalie et polypes coliques
Beckers, Albert ULg; Delhougne, B.; Deneux, C. et al

in Beckers, Albert (Ed.) Acromégalie : Les conséquences de l'hypersomatropisme (1996)

Detailed reference viewed: 33 (4 ULg)
Full Text
Peer Reviewed
See detailLe cas clinique du mois. Hemochromatose genetique
Collignon, Nathalie ULg; Delwaide, Jean ULg; Belaiche, Jacques ULg

in Revue Médicale de Liège (1996), 51(2), 150-153

Detailed reference viewed: 79 (1 ULg)
Full Text
Peer Reviewed
See detailThe prevalence of colonic polyps in acromegaly : a prospective colonoscopic and pathological study in 103 patients.
Delhougne, B.; Deneux, C.; Abs, R. et al

in Journal of Clinical Endocrinology and Metabolism (1995), 80(11), 3223-3226

Patients with acromegaly are reported to be at risk of developing adenomatous colonic polyps, which are considered to be preneoplastic lesions. This assumption is, however, usually drawn from results ... [more ▼]

Patients with acromegaly are reported to be at risk of developing adenomatous colonic polyps, which are considered to be preneoplastic lesions. This assumption is, however, usually drawn from results obtained in rather small series of patients or without a control group. We, therefore, undertook a prospective colonoscopic and pathological study comprising 103 acromegalic patients and 138 nonacromegalic control subjects referred for irritable bowel syndrome. The prevalence of adenomatous colonic polyps was significantly increased in acromegalic patients compared to that in control subjects (22.3% vs. 8.0%; P = 0.0024). The significance was similarly present in male acromegalic patients (28.6% vs. 5.5% in male control subjects; P = 0.0026), but was absent in female acromegalic patients. The prevalence of colonic polyps was also significantly increased in the group of acromegalic patients under 55 yr of age (20.0% vs. 3.0% in the control group of the same age; P = 0.0026). Other characteristics of adenomatous colonic polyps in acromegaly were the multiplicity and the presence proximal to the splenic flexure. No difference in the duration of acromegaly was found between patients with or without adenomatous polyps. The prevalence of hyperplastic colonic polyps was also significantly increased to 24.3% in acromegalic patients vs 4.4% in control subjects (P < 0.001). In conclusion, in view of the increased incidence of adenomatous colonic polyps, colonoscopy should be part of the follow-up examination in acromegaly. [less ▲]

Detailed reference viewed: 60 (5 ULg)
See detailIncreased prevalence of colonic adenomas in acromegalics patiens
Delhougne, B.; Deneux, C.; Abs, R. et al

in Belgian week of gastroenterology : Knokke, March 16th-18th 1995 - Abstract book (1995, March)

Detailed reference viewed: 15 (7 ULg)
See detailIncreased prevalence of colonic adenomas acromegalic patients
Delhougne, B.; Deneux, C.; Abs, R. et al

in Fourth Meeting of the Belgian Endocrine Society : 19 november 1994 - Abstract book (1994, November 19)

Detailed reference viewed: 9 (3 ULg)
Full Text
See detailGastroentéropathies avec pertes de protéines
Belaiche, Jacques ULg; Delwaide, Jean ULg; Louis, Edouard ULg

in Encyclopédie médico-chirurgicale (1994)

Le tractus gastro-intestinal joue un rôle important dans l'homéostasie des protéines plasmatiques, aussi bien chez le sujet normal que dans les états pathologiques. A l'état physiologique, les protéines ... [more ▼]

Le tractus gastro-intestinal joue un rôle important dans l'homéostasie des protéines plasmatiques, aussi bien chez le sujet normal que dans les états pathologiques. A l'état physiologique, les protéines présentes dans la lumière intestinale ont une double origine: exogène, constituée des protéines alimentaires, et endogène, provenant des sécrétions digestives, de la desquamation cellulaire et des protéines plasmatiques sécrétées ou exsudées. L'exagération de ce dernier mécanisme définit l'entéropathie exsudative qu'il est plus logique de dénommer gastroentéropathie exsudative ou gastroentéropathie avec pertes de protéines dans la mesure où l'estomac peut participer à t'exsudation et que les pertes portent surtout sur les protéines normalement présentes dans le sang, la lymphe et le liquide interstitel. Citrin et coll. [26] ont été les premiers, en 1957, à mettre en évidence une déperdition d'albumine marquée a l'iode 131 chez un malade présentant une maladie de Ménétrier. Le terme d'entéropathie exsudative (<< protein-losing enteropathy ») a été utilisé pour la première fois en 1959 par Gordon aux Etats-Unis et Schwartz et Jarnum au Danemark. En France, c'est à Cattan et Vésin r2~] que l'on doit les premiers travaux consacrés à cette entité. Il s'agit en fait d'un syndrome relevant de causes multiples. Dans la majorité des cas, les manifestations cliniques et biologiques de l'exsudation sont au second plan, masquées par l'affection en cause. Le diagnostic est plus rarement évoqué devant une hypoprotidémie avec ou sans syndrome oedémateux non expliquée par une origine hépatique ou rénale. [less ▲]

Detailed reference viewed: 127 (7 ULg)
Peer Reviewed
See detailH3-receptor regulation of vascular gastrin and somatostatin releases by the isolated rat stomach.
Bado, A.; Moizo, L.; Laigneau, J. P. et al

in Yale Journal of Biology and Medicine (The) (1994), 67(3-4), 113-121

We have studied the effects of the H3-receptor agonist (R) alpha-methylhistamine [(R) alpha-MeHA] and the H3-receptor antagonist thioperamide (Thiop) on basal- and carbachol-stimulated vascular gastrin ... [more ▼]

We have studied the effects of the H3-receptor agonist (R) alpha-methylhistamine [(R) alpha-MeHA] and the H3-receptor antagonist thioperamide (Thiop) on basal- and carbachol-stimulated vascular gastrin release (GR) and somatostatin release (SR) by the isolated rat stomach. Carbachol dose-dependently stimulated and inhibited GR and SR, respectively. Maximal stimulation of GR (500 +/- 112 percent of basal; p < .01), and maximal inhibition of SR (-62 +/- 9 percent under basal; p < .01) were obtained with 1 micron carbachol. Neither (R)alpha-MeHA nor Thiop, up to 10 microns, affected GR. However, SR was dose-dependently enhanced by Thiop (25 +/- 8 percent for 10 microns). Carbachol stimulation of GR was strongly inhibited by Thiop (30 +/- 7 percent for 100 nM and 73 +/- 14 percent for 1 microgram), whereas it was potentiated by (R)alpha-MeHA. Carbachol inhibition of SR was reversed by Thiop and (R)alpha-MeHA. However, the reversal effect of (R)alpha-MeHA was prevented by the CCKB/gastrin receptor antagonist PD134308. These results support H3-receptor regulation of basal and cholinergically-stimulated GR and SR. [less ▲]

Detailed reference viewed: 17 (0 ULg)
Peer Reviewed
See detailEffects of Proglumide and Enprostil on Omeprazole-Induced Fundic Endocrine Cell Hyperplasia in Rats
Delwaide, Jean ULg; Latour, Pascale ULg; Gast, Pierrette ULg et al

in Gastroentérologie Clinique et Biologique (1993), 17(11), 792-6

Long-term treatment with omeprazole induces hyperplasia of enterochromaffin-like cells, closely related to hypergastrinemia. We studied whether proglumide, an antagonist of gastrin/CCK receptor, and ... [more ▼]

Long-term treatment with omeprazole induces hyperplasia of enterochromaffin-like cells, closely related to hypergastrinemia. We studied whether proglumide, an antagonist of gastrin/CCK receptor, and enprostil, a synthetic prostaglandin E2 derivative, might inhibit this hyperplasia. Six groups of 8 rats were treated for 10 weeks: a) untreated controls; b) omeprazole 10 mumol/kg; c) proglumide 500 mg/kg; d) enprostil 30 micrograms/kg; e) association of omeprazole and proglumide; f) association of omeprazole and enprostil. Serum gastrin levels were measured at different times during treatment. After sacrifice, fundic argyrophil cells were assessed by Grimelius' staining. Serum gastrin levels and argyrophil cell density were not modified in proglumide- and enprostil-treated groups, as compared with controls. Omeprazole increased significantly these two parameters. When given with omeprazole, proglumide decreased significantly serum gastrin levels and argyrophil cell density, as compared to omeprazole alone, while enprostil did not modify significantly these two parameters. These results indicate that proglumide, but not enprostil, can counteract the omeprazole-induced argyrophil cell hyperplasia in rats. [less ▲]

Detailed reference viewed: 23 (2 ULg)
Peer Reviewed
See detailFundic Argyrophil Cell Hyperplasia in Atrophic Gastritis: A Search for a Sensitive Diagnostic Method
Belaiche, Jacques ULg; Delwaide, Jean ULg; Vivario, M. et al

in Acta Gastro-Enterologica Belgica (1993), 56(1, Jan-Feb), 11-7

Hypergastrinemia induces argyrophil cell hyperplasia in oxyntic mucosa (FACH) in patients with non-antral atrophic gastritis, with or without pernicious anemia. This proliferation favours the development ... [more ▼]

Hypergastrinemia induces argyrophil cell hyperplasia in oxyntic mucosa (FACH) in patients with non-antral atrophic gastritis, with or without pernicious anemia. This proliferation favours the development of carcinoid tumours. In order to determine the most usual appropriate method to document FACH, we have studied 29 consecutive fundic biopsies from 26 patients with fundic chronic gastritis. The study encompassed gastrinemia levels, standard histology permitting the classification of chronic gastritis, demonstration of FACH by Grimelius stain, immunohistochemical studies using NSE, chromogranin A and by electron microscopy. The FACH was classified for each stain as slight, moderate or severe. The study displayed a relationship between the grade of gastritis and the density of argyrophil endocrine cells in oxyntic mucosa assessed by Grimelius stain (p < 0.0001) and chromogranin A (P < 0.01). There was also a relationship between the serum gastrin level and the density of argyrophil endocrine cells detected by these two stains (p < 0.001). A highly significant correlation was observed between Grimelius stain and chromogranin A (p < 0.0001). On the other hand, no significant correlation was noted with either NSE or electron microscopy. We conclude that Grimelius stain and immunohistochemical studies against chromogranin A were the best methods for the demonstration of FACH in atrophic gastritis. One of these two techniques is sufficient in current practice for defining the patients at risk for subsequent surveillance. [less ▲]

Detailed reference viewed: 28 (6 ULg)
Full Text
Peer Reviewed
See detailPhysiologie de la cellule enterochromaffin-like (ECL) dans la régulation de la sécrétion gastrique acide
Delwaide, Jean ULg; Belaiche, Jacques ULg; Latour, Pascale ULg

in Médecine & Chirurgie Digestives (1993), 22

Cette mise au point rappellera d'abord les grands mécanismes de la sécrétion gastrique acide en insistant sur le rôle pivot de l'histamine. Une question qui demeurait encore non résolue était de savoir ... [more ▼]

Cette mise au point rappellera d'abord les grands mécanismes de la sécrétion gastrique acide en insistant sur le rôle pivot de l'histamine. Une question qui demeurait encore non résolue était de savoir quelle était la cellule fundique qui produisait de l'histamine dans les conditions physiologiques. Deux cellules seront envisagées, les mastocytes et les cellules ECL qui sont des cellules endocrines exclusivement localisées dans le fundus. Quelques arguments seront développés, dont ceux provenant de notre expérience, permettant de penser que la cellule ECL contient de l'histamine. L'article se terminera par un essai d'intégration de la cellule ECL dans le schéma de la sécrétion gastrique acide en montrant son rôle essentiel potentiel. [less ▲]

Detailed reference viewed: 36 (4 ULg)
Full Text
Peer Reviewed
See detailApports récents de la génétique dans les maladies inflammatoires intestinales
Louis, Edouard ULg; Belaiche, Jacques ULg; Franchimont, D. et al

in Acta Clinica Belgica (1993), 48(6), 383-91

It is clear since many years that the liability to develop inflammatory bowel disease is influenced by genetic factors. Recent progresses in the field of genetic markers and genetic models bring the ... [more ▼]

It is clear since many years that the liability to develop inflammatory bowel disease is influenced by genetic factors. Recent progresses in the field of genetic markers and genetic models bring the concept of genetic heterogeneity. This new concept leads us to try to classify different forms of inflammatory bowel disease and could have in the future an impact on the prevention, the follow up and the treatment of these diseases. [less ▲]

Detailed reference viewed: 25 (4 ULg)
Peer Reviewed
See detailLes cellules ECL et leurs récepteurs: rôle physiologique et intérêt physiopathologique
Belaiche, Jacques ULg; Delwaide, Jean ULg; Louis, Edouard ULg et al

in Acta Gastro-Enterologica Belgica (1993), 56(3-4, May-Aug), 235-44

The enterochromaffin-like (ECL) cells represent the predominating endocrine cell population in the oxyntic mucosa of the stomach. They are under the influence of gastrin. Recently, a histamine production ... [more ▼]

The enterochromaffin-like (ECL) cells represent the predominating endocrine cell population in the oxyntic mucosa of the stomach. They are under the influence of gastrin. Recently, a histamine production was shown within the secretory granules of ECL cells. ECL cells appear to play a crucial role in the physiology of gastric acid secretion. There are many unknowns concerning the intervention of other trophic factors in addition to gastrin and concerning the receptors located on the cells. ECL cell hyperplasia is a well documented consequence of hypergastrinemia. The latter can result from a gastrinoma or from a reduction of gastric acid secretion related to pernicious anemia or to long-term treatment with antisecretory drugs. [less ▲]

Detailed reference viewed: 32 (3 ULg)
See detailLes cellules enterochromaffin-like (ECL) : de la physiologie à la pathologie
Belaiche, Jacques ULg; Delwaide, Jean ULg; Louis, Edouard ULg et al

in Médecine et Hygiène (1992), 50

Detailed reference viewed: 17 (2 ULg)